Many randomized Phase III trials of cancer therapy involve quality of life assessments. This paper argues for graphical presentation of quality of life measures in order to visualize changes over time.
CITATION STYLE
Machin, D. (1997). Assessing quality of life in comparative cancer clinical trials: Does it make a difference? Controlled Clinical Trials, 18(4), 301–305. https://doi.org/10.1016/S0197-2456(96)00177-8
Mendeley helps you to discover research relevant for your work.